Drugs Made In America Acquisition II Corp. (DMII)

Drugs Made In America Acquisition II Corp. (DMII) is a financial services company (shell companies) based in the United States. The share price is $10.24, up 0.00% on the day, which values the company at $652.45M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$10.24+0.00% today
Market value
$652.45M
P/E ratio
34.1×last 12 months
Sector
Financial Services

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Drugs Made In America Acquisition II Corp. in more detail

DMII trades at 34.1× its last twelve months' earnings.

Worth checking: Profit is not turning into cash.

1 of the superinvestors tracked here hold DMII, including Louis Bacon (0.2% of the portfolio).

Superinvestors holding DMII

1 of the investors tracked here report a position in their latest 13F filing.

Drugs Made In America Acquisition II Corp. (DMII): questions and answers

What is DMII's P/E ratio?

Drugs Made In America Acquisition II Corp. trades at 34.1× its last twelve months' earnings.

What is Drugs Made In America Acquisition II Corp.'s market cap?

Drugs Made In America Acquisition II Corp. is valued at $652.45M at a share price of $10.24.

Does DMII pay a dividend?

Drugs Made In America Acquisition II Corp. does not currently pay a regular dividend.

Which famous investors own DMII?

In their latest quarterly filings, Louis Bacon (0.2% of the portfolio) hold DMII. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Drugs Made In America Acquisition II Corp. (DMII) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DMII

Underlying data: Yahoo Finance; company filings with the SEC.